The latest report by IMARC Group, titled “Artificial Intelligence in Healthcare Market Report by Offering (Hardware, Software, Services), Technology (Machine Learning, Context Aware Computing, Natural Language Processing, and Others), Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), End-User (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Patients, and Others), and Region 2024-2032“, The global artificial intelligence in healthcare market size reached US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.2 Billion by 2032, exhibiting a growth rate (CAGR) of 27.4% during 2024-2032.

Factors Affecting the Growth of the Artificial Intelligence in Healthcare Industry:

• Advanced Data Analytics and Insights:

The increasing volume and complexity of healthcare data, including electronic health records (EHRs), medical imaging, genomic data, and real-time patient monitoring, necessitate advanced analytics solutions powered by AI. AI algorithms can efficiently analyze vast amounts of data to extract valuable insights, identify patterns, predict outcomes, and support clinical decision-making. By enabling healthcare providers to leverage data-driven insights, AI enhances diagnostic accuracy, personalizes treatment plans, optimizes resource allocation, and improves patient outcomes, driving the adoption of AI technologies across the healthcare industry and thus fueling the market growth.

• Rapid Technological Advancements:

Ongoing advancements in AI technologies, such as machine learning, natural language processing (NLP), computer vision, and predictive analytics, are expanding the scope and capabilities of AI applications in healthcare. These advancements enable the development of more sophisticated AI algorithms and solutions capable of addressing diverse healthcare challenges, from disease diagnosis and treatment planning to drug discovery and population health management. Additionally, the integration of AI with other emerging technologies like Internet of Things (IoT) devices, wearable sensors, and telemedicine platforms further enhances its potential to revolutionize healthcare delivery, making AI a key driver of innovation and transformation in the healthcare industry.

• Growing Demand for Healthcare Efficiency and Quality:

Rising healthcare costs, increasing patient volumes, and growing demand for quality care are driving healthcare organizations to seek innovative solutions that improve operational efficiency, reduce medical errors, and enhance patient satisfaction. AI technologies offer opportunities to automate routine tasks, streamline workflows, and augment healthcare professionals' capabilities, enabling them to focus on higher-value activities and provide more personalized, timely, and effective care. Moreover, AI-powered solutions facilitate early disease detection, preventive interventions, and proactive management of chronic conditions, ultimately leading to better health outcomes and cost savings. As healthcare stakeholders recognize the potential benefits of AI in addressing these challenges, there has been a rise in demand for AI-enabled healthcare solutions, driving market expansion and investment in AI technologies within the healthcare sector.

Competitive Landscape with Key Player:

• Amazon Web Services Inc.
• Cloudmedx Inc.
• DeepMind
• Enlitic Inc.
• General Vision Inc.
• Google Inc.
• International Business Machines
• iCarbonX
• Intel Corporation
• Medtronic
• Micron Technology Inc.
• Microsoft Corporation
• Next It Corporation
• Nuance Communications Inc.
• Nvidia Corporation
• Siemens Healthcare
• Welltok Inc.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/artifical-intelligence-healthcare-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Offering:

• Hardware
• Software
• Services

Software represents the leading segment due to its adaptability and ability to analyze vast amounts of healthcare data efficiently.

Breakup by Technology:

• Machine Learning
• Context-Aware Computing
• Natural Language Processing
• Others

Machine learning accounts for the largest market share owing to its capability to analyze complex datasets and generate insights for personalized treatment recommendations.

Breakup by Application:

• Robot-Assisted Surgery
• Virtual Nursing Assistant
• Administrative Workflow Assistance
• Fraud Detection
• Dosage Error Reduction
• Clinical Trial Participant Identifier
• Preliminary Diagnosis
• Others

Clinical trial participant identifier represents the largest segment as it streamlines patient recruitment processes and enhances trial efficiency.

Breakup by End-User:

• Healthcare Providers
• Pharmaceutical and Biotechnology Companies
• Patients
• Others

Pharmaceutical and biotechnology companies hold the majority of the market share on account of their extensive utilization of AI technologies in drug discovery and development.

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America's dominance in artificial intelligence in healthcare market is attributed to its advanced technological infrastructure and strong regulatory framework.

Global Artificial Intelligence in Healthcare Market Trends:

The global artificial intelligence in the healthcare market is primarily driven by the increasing adoption of AI technologies in healthcare that is fueled by the growing need for efficient and accurate diagnosis, treatment, and patient care. AI enables healthcare providers to analyze large volumes of medical data, including electronic health records, medical images, and genomic information, to generate valuable insights and support clinical decision-making processes. Moreover, ongoing advancements in AI technologies, particularly in machine learning and deep learning algorithms, are expanding the capabilities and applicability of AI in healthcare, driving innovation and the development of new AI-driven solutions. Furthermore, rising healthcare costs, aging populations, and the prevalence of chronic diseases are driving demand for AI-powered solutions that improve operational efficiency, reduce medical errors, and enhance patient outcomes, thus contributing to market growth.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163